Ravit Barkama, Ami Mayo, Alona Paz, Anna Solopov, Tal Mann, Zahava Vadasz, Tal Appel, Racheli Ofir, Liran Shani, Michal Sheleg, Hoshea Allen, Rony Shaked Nitzan, Nurit Tsarfaty, Hadar Gilad, Thomas Birch, Erez Kachel, Petra Reinke, Hans-Dieter Volk, Ronen Zalts, Ayelet Raz Pasteur
OBJECTIVES: To determine whether placental cell therapy PLacental eXpanded (PLX)-PAD (Pluristem Therapeutics, Haifa, Israel) may be beneficial to treating critically ill patients suffering from acute respiratory distress syndrome due to coronavirus disease 2019. DESIGN: Retrospective case report of critically ill coronavirus disease 2019 patients treated with PLacental eXpanded (PLX)-PAD from March 26, 2020, to April 4, 2020, with follow-up through May 2, 2020. SETTING: Four hospitals in Israel (Rambam Health Care Campus, Bnai Zion Medical Center, and Samson Assuta Ashdod University Hospital), and Holy Name Medical Center in New Jersey...
September 2020: Critical care explorations